Products
10708 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Netflix Constant Leverage with ISIN code: CH1396328721 | Netflix | Constant Leverage | Short | ― | 98.805 | 0.037 | 0.001 | 0.038 | 1 | -2.63% | -92.29% | -96.44% | 12 Feb. 2025 | |
| Netflix Constant Leverage with ISIN code: CH1396328739 | Netflix | Constant Leverage | Short | ― | 98.805 | 0.32 | 0.010 | 0.33 | 1 | -3.03% | -85.05% | -90.99% | 12 Feb. 2025 | |
| Netflix Constant Leverage with ISIN code: CH1423417521 | Netflix | Constant Leverage | Short | ― | 98.805 | 0.66 | 0.010 | 0.67 | 1 | -1.49% | -93.99% | -98.08% | 13 Jun. 2025 | |
| Newmont Constant Leverage with ISIN code: CH1450970046 | Newmont | Constant Leverage | Short | ― | 115.019 | 0.002 | ― | ― | 1 | 100.00% | 100.00% | -84.62% | 3 Nov. 2025 | |
| Newmont Constant Leverage with ISIN code: CH1450970053 | Newmont | Constant Leverage | Short | ― | 115.019 | 0.019 | 0.001 | 0.02 | 1 | 18.75% | 58.33% | -75.95% | 3 Nov. 2025 | |
| Newmont Constant Leverage with ISIN code: CH1450968743 | Newmont | Constant Leverage | Short | ― | 115.019 | 0.026 | 0.001 | 0.027 | 1 | 13.04% | 52.94% | -59.38% | 21 Aug. 2025 | |
| Newmont Constant Leverage with ISIN code: CH1423416010 | Newmont | Constant Leverage | Short | ― | 115.019 | 0.077 | 0.001 | 0.078 | 1 | 13.24% | 37.50% | -45.00% | 7 May. 2025 | |
| Nike Constant Leverage with ISIN code: CH1119067994 | Nike | Constant Leverage | Short | ― | 57.565 | 0.67 | 0.010 | 0.68 | 1 | 6.35% | 42.55% | 26.42% | 12 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969097 | Nokia | Constant Leverage | Short | ― | 6.693 | 0.01 | 0.003 | 0.013 | 1 | 0.00% | -50.00% | -71.43% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 6.693 | 0.033 | 0.003 | 0.036 | 1 | 0.00% | -28.26% | -46.77% | 30 Nov. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 124.897 | 0.12 | 0.030 | 0.15 | 1 | 9.09% | -14.29% | -40.00% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 124.897 | 0.71 | 0.030 | 0.74 | 1 | 5.97% | 4.41% | -23.66% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 124.897 | 0.029 | 0.003 | 0.032 | 1 | 26.09% | 3.57% | -49.12% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 124.897 | 0.023 | 0.003 | 0.026 | 1 | 0.00% | -4.17% | -34.29% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 124.897 | 0.082 | 0.003 | 0.085 | 1 | 22.39% | 12.33% | -54.44% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 248.315 | 0.24 | 0.030 | 0.27 | 1 | -14.29% | -36.84% | -20.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 248.315 | 6.29 | 0.080 | 6.37 | 1 | -4.84% | -21.38% | 3.80% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 248.315 | 0.015 | ― | ― | 1 | -11.76% | -44.44% | -40.00% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1450969840 | Nvidia | Constant Leverage | Short | ― | 179.39 | 6.26 | 0.020 | 6.28 | 1 | 12.19% | 12.59% | -45.23% | 3 Nov. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1362351657 | Nvidia | Constant Leverage | Short | ― | 179.39 | 0.16 | 0.010 | 0.17 | 1 | 0.00% | 0.00% | -27.27% | 27 Nov. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.